Ingevity (NGVT) Projected to Announce Quarterly Earnings on Wednesday

Ingevity (NYSE:NGVT) is expected to post its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to post earnings of $1.31 per share and revenue of $312.20 million for the quarter. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Individuals can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.31. The company had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The company’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.01 earnings per share. On average, analysts expect Ingevity to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Ingevity Stock Performance

Shares of NGVT stock opened at $74.30 on Tuesday. The company has a market capitalization of $2.58 billion, a price-to-earnings ratio of -20.93 and a beta of 1.16. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. The company has a 50-day simple moving average of $71.23 and a 200 day simple moving average of $70.77. Ingevity has a 52 week low of $39.74 and a 52 week high of $79.29.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 7th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $80.00.

Insider Buying and Selling

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at $493,264.98. The trade was a 6.44% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.88% of the stock is currently owned by company insiders.

Institutional Trading of Ingevity

Several large investors have recently modified their holdings of the stock. Advisory Services Network LLC raised its stake in Ingevity by 4.4% in the third quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock valued at $383,000 after purchasing an additional 293 shares in the last quarter. Amundi increased its holdings in Ingevity by 4.8% in the 3rd quarter. Amundi now owns 6,626 shares of the company’s stock valued at $364,000 after buying an additional 302 shares during the period. Geneos Wealth Management Inc. raised its position in shares of Ingevity by 85.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after buying an additional 387 shares in the last quarter. Global Retirement Partners LLC acquired a new position in shares of Ingevity in the 4th quarter valued at approximately $27,000. Finally, CANADA LIFE ASSURANCE Co lifted its holdings in shares of Ingevity by 1.6% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 30,116 shares of the company’s stock worth $1,782,000 after acquiring an additional 485 shares during the period. 91.59% of the stock is owned by institutional investors and hedge funds.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.